Antigen vs Antibody – What Are the Differences?
Article Oct 25, 2017
Antigens are molecules capable of stimulating an immune response. Each antigen has distinct surface features, or epitopes, resulting in specific responses.
Antibodies (immunoglobins) are Y-shaped proteins produced by B cells of the immune system in response to exposure to antigens. Each antibody contains a paratope which recognizes a specific epitope on an antigen, acting like a lock and key binding mechanism. This binding helps to eliminate antigens from the body, either by direct neutralization or by ‘tagging’ for other arms of the immune system.
Comparison Chart on Differences Between Antigen & Antibody
Substance that can induce an immune response
Proteins that recognize and bind to antigens
Usually proteins, may also be polysaccharides, lipids or nucleic acids
Within the body or externally
Within the body
Specific binding site
The Role of Antigens & Antibodies in Vaccinations
Vaccines contain antigens which stimulate the B lymphocytes of the immune system to respond by producing plasma cells which secrete disease specific antibodies (Primary response). Some of the B cells become memory B cells, which will recognise future exposure to the disease. This results in a faster and more intense production of antibodies, which effectively work to eliminate the disease by binding to the antigens (Secondary response).
Microfluidic Method Identifies Rare Antibodies with Therapeutic PotentialArticle
A novel microfluidic platform, able to rapidly isolate and identify rare antibodies from a vast repertoire of human B cells, has been developed by scientists. This technology could possess the ability to support and enhance the development of novel vaccines and biopharmaceuticals in the future.READ MORE
Developments in Continuous Cell CultureArticle
Continuous cell culture is part of a trend in bioprocessing towards highly productive, streamlined, and interconnected unit operations. While continuous processing has a long history in various industries, regulatory concerns have stalled widespread adoption of continuous bioprocessing. That is beginning to change as the industry acclimates to regulators’ desire for risk- and science-based production decisions.READ MORE
The Viral Genome: Moving Beyond Reading Code – Why Not Rewrite It?Article
Researchers have discovered how to read, decode, and manipulate previously ‘hidden’ viral code. This could open up new opportunities in drug delivery and gene therapy.READ MORE